OVERVIEW

Total Health Conferencing's 2023 ASCO Direct™ Philadelphia Conference is an officially licensed Best of ASCO meeting. This Post ASCO Review will showcase abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an hybrid conference, featuring in-person attendance with virtual and on-demand access for registered attendees.

LEARNING OBJECTIVES

• Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer. 
• Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers. 
• Stimulate innovative strategies for new and additional research related to treatment and prevention. 
• Recognize the implications for practice change in both the academic and community practice settings. 

ACCREDITATION

Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For more information please visit the official event page.